$Moderna (MRNA.US)$ Stephane Bancel, CEO of Moderna, expects...

$Moderna(MRNA.US)$ Stephane Bancel, CEO of Moderna, expects to have no problems developing booster needles for the Omicron variant and could start work in a few weeks. Moderna hopes to begin clinical trials of the vaccine early next year to curb the rapid spread of the Omicron variant, but is focusing on developing a booster shot for the MRNA-1273 coronavirus vaccine. Previously, Moderna said its booster shot boosted antibody levels against the Omicron variant. Bancel said the vaccine against the Omicron variant would require only minor tweaks to existing COVID-19 vaccines.